Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Public Comment topic
No spam. Unsubscribe anytime.
Public commenters urge board to examine AI in prior authorizations and prescription cost impacts
Summary
Two public commenters asked the PEBB board about Premera/MultiCare contract timing and whether experimental federal AI use in prior‑authorization decisions and federal prescription initiatives could affect members; staff said they will take comments under advisement and research vetting carriers’ use of AI.
During the public comment period, Aruna Huta of Spokane asked whether the Premera‑MultiCare temporary extension through June 30, 2026 would affect members enrolled in Medicare supplement plans and requested that retiree benefit information be shared with employees transitioning to private sector work. Huta said the timing of carrier contract changes was a concern for Spokane area members.
Fred Gancy raised two concerns: a federal trial program he understood to be testing AI for denying services and the potential effect of federal prescription policy changes on drug costs and Part D usage. He asked whether the board or staff had examined how carriers use automated decision tools and how federal prescription initiatives might affect members; staff recorded the comments and said they would investigate and report back.
